Intuitive Surgical outperforms competition by 5.2% on Tuesday

Trending News 🌥️

Intuitive Surgical Stock Fair Value – The company’s flagship product is the da Vinci surgical system, which is used in a variety of surgical procedures including general surgery, urology, gynecology, and cardiothoracic surgery. Intuitive Surgical ($NASDAQ:ISRG) Inc.’s stock traded up 5.2% on Tuesday, outperforming its competitors by a significant margin. The company’s strong performance was driven by positive earnings results and favorable analyst commentary.

Looking ahead, Intuitive Surgical Inc. is well-positioned to continue its strong performance. The company’s da Vinci surgical system is the market leader in its field, and with continued innovation and expansion into new markets, Intuitive Surgical Inc. is poised for continued growth.

Share Price

So far, the news regarding the company has been mostly positive. On Monday, Intuitive Surgical stock opened at $243.0 and closed at $246.5, up by 0.9% from its last closing price of 244.2. This trend continued on Tuesday, with the stock rising even further.

VI Analysis – Intuitive Surgical Stock Fair Value

Intuitive Surgical is a medical device company that manufactures robotic surgical systems. The company’s flagship product is the da Vinci surgical system, which is used in a variety of minimally invasive surgical procedures. The company’s fundamentals reflect its long-term potential. The company has strong financials, with a history of profitability and positive cash flow.

It also has a strong competitive position in the market, with a leading product and a large installed base. The fair value of Intuitive Surgical shares is around $298.0, based on the company’s fundamentals. The stock is currently trading at $246.5, which represents a fair price undervalued by 17%.

VI Peers

The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.

– Stryker Corp ($NYSE:SYK)

With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.

– Medtronic PLC ($NYSE:MDT)

Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.

– Becton, Dickinson and Co ($NYSE:BDX)

Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.

Summary

Investing in Intuitive Surgical Inc. can be a smart move for long-term investors. The company is a global leader in developing and manufacturing robotic-assisted surgical systems and has a strong competitive advantage in this growing market. The company continues to post strong financial results, with revenue and earnings growing at a double-digit clip.

ISRG is also expanding its addressable market by launching new products and expanding into new geographies. With its strong market position and favorable growth prospects, ISRG is a stock that should be on the radar of long-term investors.